Pembrolizumab Market Size, Share & Industry Analysis, By Product Type (KEYTRUDA IV and KEYTRUDA QLEX / SC Pembrolizumab), By Disease Indication (NSCLC, Melanoma, HNSCC, Urothelial Carcinoma, RCC, TNBC, Gastric/GEJ/Esophageal Cancers, Cervical Cancer, and Others), By Age Group (Pediatric and Adults), By Type (Branded and Biosimilar), By Therapy Setting (Early-stage / Perioperative, Advanced / Metastatic, and Others), By Route of Administration (IV and SC), By End User (Hospitals, Specialty Cancer Clinics, Ambulatory Infusion Centers, and Others), and Regional Forecast, 2026-2034